Literature DB >> 2645816

Effect of vaccination with a pentavalent leptospiral vaccine on Leptospira interrogans serovar hardjo type hardjo-bovis infection of pregnant cattle.

C A Bolin1, A B Thiermann, A L Handsaker, J W Foley.   

Abstract

Effectiveness of a pentavalent leptospiral vaccine to protect cattle from infection and reproductive problems caused by Leptospira interrogans serovar hardjo type hardjo-bovis was evaluated. Seven cows were vaccinated once and 8 cows were vaccinated twice with a USDA-licensed pentavalent leptospiral vaccine. Five cows were maintained as nonvaccinated controls. Cows were bred 1 to 2 months after the last vaccination. During the 4th to 6th month of gestation, all cows were challenge exposed on 4 occasions by conjunctival instillation of 10(8) serovar hardjo type hardjo-bovis organisms and on 3 occasions by conjunctival instillation of urine from a cow shedding hardjo-bovis. All control cows and 13 of 15 vaccinated cows became infected and shed leptospires in the urine. Leptospires were detected in fewer urine samples collected from vaccinated cows, compared with those collected from control cows. Four stillborn calves and 3 weak calves were born to control and vaccinated cows. Leptospires were detected in the kidneys of 11 apparently healthy calves born to vaccinated and control cows. Agglutinating antibodies were not detected in the precolostral serum of these calves.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645816

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  21 in total

1.  Protein and antigen profiles of prevalent serovars of Leptospira interrogans.

Authors:  J A Brown; R B LeFebvre; M J Pan
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization.

Authors:  Richard L Zuerner; David P Alt; Mitchell V Palmer; Tyler C Thacker; Steven C Olsen
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

3.  Serological titers to various leptospiral serovars before and after vaccinating gilts with three commercial vaccines.

Authors:  S E Sanford; P J Morris
Journal:  Can Vet J       Date:  1990-04       Impact factor: 1.008

4.  A survey of house mice from Iowa swine farms for infection with Leptospira interrogans serovar bratislava.

Authors:  K E Smith; J J Zimmerman; C A Bolin; G W Beran; H T Hill
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

5.  Neospora caninum and Leptospira serovar serostatus in dairy cattle in Ontario.

Authors:  Andrew S Peregrine; S Wayne Martin; Douglas A Hopwood; Todd F Duffield; Beverly McEwen; Jamie C Hobson; Sharon K Hietala
Journal:  Can Vet J       Date:  2006-05       Impact factor: 1.008

6.  Leptospirosis in beef herds from western Canada: serum antibody titers and vaccination practices.

Authors:  Leanne M Van De Weyer; Steve Hendrick; Leigh Rosengren; Cheryl L Waldner
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

7.  Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.

Authors:  D A Haake; M K Mazel; A M McCoy; F Milward; G Chao; J Matsunaga; E A Wagar
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species.

Authors:  E S Shang; T A Summers; D A Haake
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

9.  The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection.

Authors:  D A Haake; G Chao; R L Zuerner; J K Barnett; D Barnett; M Mazel; J Matsunaga; P N Levett; C A Bolin
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

10.  Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes.

Authors:  B M Naiman; D Alt; C A Bolin; R Zuerner; C L Baldwin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.